Over 2,000 British Columbians are diagnosed with blood cancers each year. Fueled by a revolution in next generation sequencing, remarkable advances in stem cell biology and methods for disease modelling, our understanding of how blood cancers develop has expanded tremendously over the past decade.

With this new knowledge comes an unprecedented opportunity to identify and develop more effective targeted drugs or immune-based treatments that will improve the standard of care for all British Columbians.

It is now more important than ever that we understand the subtle differences among blood cancer sub-types at the genetic level. With this knowledge in hand, new treatment strategies developed in the lab will be delivered to patients in the clinic, tailored to specific individuals as much as possible.

Led by a brilliant team at BC Cancer, blood cancer research is on the verge of a major paradigm shift. Future success will require innovative, thoughtful leaders and increased collaboration between scientists, clinicians and teams of health care professionals.

With YOUR help BC CAN change the outcome.